Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
   Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
   
  
  
  December 16, 2021
  From Benzinga
 
   GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
   
  December 15, 2021
  Tickers 
   GOVX
  
  
  From Benzinga
 
   Eli Lilly Shares Gain After Boosting 2021 Profit, Sales Forecast; Issues 2022 Guidance
   
  December 15, 2021
  Tickers 
   LLY
  
  
  From Benzinga
 From Benzinga
 
   Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
   
  
  
  December 15, 2021
  From Benzinga
 
   Why Are Vir Biotech Shares Gaining Today?
   
  
  
  December 15, 2021
  From Benzinga
 
   Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination
   
  December 15, 2021
  Tickers 
   OCGN
  
  
  From Benzinga
 
   After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
   
  
  
  December 15, 2021
  From Benzinga
 
   South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine Protection
   
  
  
  December 14, 2021
  From Benzinga
 
   Serum Institute's CEO Expects To Launch Novavax Vaccine For Kids In Six Months: Reuters
   
  December 14, 2021
  Tickers 
   NVAX
  
  
  From Benzinga
 
   Moderna, Australia Collaborate To Bring mRNA Manufacturing To Australia
   
  December 14, 2021
  Tickers 
   MRNA
  
  
  From Benzinga
 
   Samsung Biologics, AstraZeneca Expand Collaboration To Include COVID-19, Cancer Therapy
   
  
  
  December 14, 2021
  From Benzinga
 
   Final Data Reaffirms Efficacy Of Pfizer's COVID-19 Antiviral Treatment
   
  December 14, 2021
  Tickers 
   PFE
  
  
  From Benzinga
 
   Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing
   
  December 10, 2021
  Tickers 
   APDN
  
  
  From Benzinga
 
   FDA Expands Emergency Use Of Pfizer/BioNTech's COVID-19 Booster To 16 Years & Older
   
  
  
  December 09, 2021
  From Benzinga
 
   AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In Immunocompromised
   
  
  
  December 09, 2021
  From Benzinga
 
   Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study Shows
   
  
  
  December 08, 2021
  From Benzinga
 
   Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
   
  
  
  December 07, 2021
  From Benzinga
 
   Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
   
  
  
  December 07, 2021
  From Benzinga
 
   Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ
   
  
  
  December 07, 2021
  From Benzinga
 
   FDA Enlists Thermo Fisher, Google-Backed Verily COVID-19 Tests Likely To Be Affected By Omicron
   
  
  
  December 07, 2021
  From Benzinga
 
   Anixa Biosciences Says COVID-19 Compounds Potentially Effective Against Omicron Variant
   
  December 07, 2021
  Tickers 
   ANIX
  
  
  From Benzinga
 
   Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
   
  December 07, 2021
  Tickers 
   GSK
  
  
  From Benzinga
 
   Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
   
  
  
  December 07, 2021
  From Benzinga
 From Benzinga
 
   RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations
   
  December 06, 2021
  Tickers 
   RDHL
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.